On January 24, 2023, the HemoVR Core Team met in Basel to finalize preparations for the 2023 MVP launch of our innovative VR tool for hemophilia patients, caregivers and healthcare professionals. We strive to enable hemophilia patients to learn about the treatment options they have and how EHLs / Factor VIII can allow them to have a more carefree active life.

On January 24, 2023, the HemoVR Core Team met in Basel to finalize preparations for the 2023 MVP launch of our innovative VR tool for hemophilia patients, caregivers and healthcare professionals. We strive to enable hemophilia patients to learn about the treatment options they have and how EHLs / Factor VIII can allow them to have a more carefree active life.

On January 24, 2023, the HemoVR Core Team met in Basel to finalize preparations for the 2023 MVP launch of our innovative VR tool for hemophilia patients, caregivers and healthcare professionals. We strive to enable hemophilia patients to learn about the treatment options they have and how EHLs / Factor VIII can allow them to have a more carefree active life.

On January 24, 2023, the HemoVR Core Team met in Basel to finalize preparations for the 2023 MVP launch of our innovative VR tool for hemophilia patients, caregivers and healthcare professionals. We strive to enable hemophilia patients to learn about the treatment options they have and how EHLs / Factor VIII can allow them to have a more carefree active life.

On January 24, 2023, the HemoVR Core Team met in Basel to finalize preparations for the 2023 MVP launch of our innovative VR tool for hemophilia patients, caregivers and healthcare professionals. We strive to enable hemophilia patients to learn about the treatment options they have and how EHLs / Factor VIII can allow them to have a more carefree active life.

On January 24, 2023, the HemoVR Core Team met in Basel to finalize preparations for the 2023 MVP launch of our innovative VR tool for hemophilia patients, caregivers and healthcare professionals. We strive to enable hemophilia patients to learn about the treatment options they have and how EHLs / Factor VIII can allow them to have a more carefree active life.